Metabolic activity of neutrophils in patients suffering from chronic viral hepatitis

Medical Science Monitor

Volumn 6, Issue 6, 2000, Pages 1136-1141

  Pawlowska, E ^a   Ciecko Michalska I ^a   Bogdal J ^a   Turowski, G ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Liver disease; Metabolic activity; NBT reduction test; Neutrophils

Indexed keywords

ADULT; AGED; ARTICLE; CELL ACTIVITY; CELL COUNT; CELL METABOLISM; CELL STIMULATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; NEUTROPENIA; NEUTROPHIL; VIRUS HEPATITIS;

ADULT; AGED; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NEUTROPHILS; NITROBLUE TETRAZOLIUM;

EID: 0034537335     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The immunology of liver disease
2. Effect of thymic extract on allogeneic MLR and mitogen-induced responses in patients with chronic active hepatitis B
3. Selected parameters of cellular immunity in children with chronic hepatitis
4. The concept of autoimmune liver disease
5. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in routine models of endotoxin and Fas-antibody-induced liver injury
6. Clinical significance of neutrophil functional activity in HIV infection
7. Wspólłczesne pogla̧dy na rolȩ granulocytów obojȩlłnochlonnych (neutrofilów) w procesach zapalnych I. Patofizjologiczne podstawy udzialłu neutrofilów w zapaleniu
8. Biochemistry of inflammatory processes and vascular injury. Role of neutrophils: A review
9. Molecular events in the activation of human neutrophils for microbial killing
10. Disorders of neutrophil function
11. Acquired neutrophil dysfunction and diseases with an inflammatory component
12. Analysis of circulating phagocyte activity measured by whole blood luminescence: Correlations with clinical status
13. Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection
14. Infection and nitroblue tetrazolium reduction by neutrophils. A diagnostic aid
15. NBT test stimulated
16. Ocena aktywności metabolicznej granulocytów obojȩlłnochlonnych w testach redukcji NBT u chorych na gruczolak i raka stercza
17. Primary inherited defects in neutrophil function: Etiology and treatment
18. In vitro study of neutrophil apoptosis in liver cirrhosis
19. Testy NBT w wybranych przypadkach chotych z glejakami mózgu
20. Testy redukcji NBT u chorych na reumatoidalne zapalenie stawów i zesztywniajca̧ce zapalenie stawów kregoslłupa
21. Immune system in patients with osteoporosis of 3rd degree. Selected parameters of immune reactivity
22. Wybrane parametry reaktywności immunologicznej chorych z czuciowo-nerwowym upośledzeniem stuchu. III. Aktywność metaboliczna granulocytów obojȩtnochlłonnych
23. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: Influence of viral load, viral genotype, and cell phenotype
24. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia and leukoDNAemia
25. Endotoxin-induced cytokine gene expression and excretion in the liver
26. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease
27. Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysacchatide administration
28. Cellular adhesion molecules: Regulation and functional significance in the pathogenesis of liver diseases
29. Glutathione peroxidase-deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: Importance of an intracellular oxidant stress
30. Interferon treatment for chronic hepatitis B or C infection: Costs and effectiveness
31. Adverse reactions to interferon alpha (INF α) treatment in children with chronic viral hepatitis
32. Long-term results of interferon alpha treatment in children with chronic hepatitis B